This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
WSH | Series Notice | 25/03/11 | ||
WSH | Appendix 1B | 25/03/11 | ||
WSH | Information Memorandum | 25/03/11 | ||
WSH | Master Trust Deed | 25/03/11 | ||
WSH | Security Trust Deed | 25/03/11 | ||
WSH | Admission to Official List | PRICE SENSITIVE | 25/03/11 | |
WSHSeries Notice | |||
25/03/11 | |||
WSHAppendix 1B | |||
25/03/11 | |||
WSHInformation Memorandum | |||
25/03/11 | |||
WSHMaster Trust Deed | |||
25/03/11 | |||
WSHSecurity Trust Deed | |||
25/03/11 | |||
WSHAdmission to Official List | |||
25/03/11 | PRICE SENSITIVE | ||